Error: Could not add to watchlist. X
+ Watchlist

Aegerion Pharmaceuticals Inc

AEGR:US
Acquired
AEGR:US was acquired by NVLN:CN
USD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-4.66
Market Cap (USD)
-
Shares Outstanding (m)
29.545
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.11%
% Price Change
-0.53%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company researches small-molecule therapeutics for cardiovascular and metabolic disease. Aegerion's product candidates limit secretion of cholesterol and triglycerides.
Address
101 Main Street
Suite 1850
Cambridge, MA 02142
United States
Phone
1-617-500-7867
Show More